21-46120507-T-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001849.4(COL6A2):​c.1333-8T>C variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.214 in 1,512,874 control chromosomes in the GnomAD database, including 37,201 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.18 ( 2760 hom., cov: 34)
Exomes 𝑓: 0.22 ( 34441 hom. )

Consequence

COL6A2
NM_001849.4 splice_region, splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.0001797
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.804
Variant links:
Genes affected
COL6A2 (HGNC:2212): (collagen type VI alpha 2 chain) This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 21-46120507-T-C is Benign according to our data. Variant chr21-46120507-T-C is described in ClinVar as [Benign]. Clinvar id is 93906.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr21-46120507-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.295 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
COL6A2NM_001849.4 linkuse as main transcriptc.1333-8T>C splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000300527.9 NP_001840.3
COL6A2NM_058174.3 linkuse as main transcriptc.1333-8T>C splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000397763.6 NP_478054.2
COL6A2NM_058175.3 linkuse as main transcriptc.1333-8T>C splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant NP_478055.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
COL6A2ENST00000300527.9 linkuse as main transcriptc.1333-8T>C splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 NM_001849.4 ENSP00000300527 P1P12110-1
COL6A2ENST00000397763.6 linkuse as main transcriptc.1333-8T>C splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 5 NM_058174.3 ENSP00000380870 P12110-2
COL6A2ENST00000409416.6 linkuse as main transcriptc.1333-8T>C splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 5 ENSP00000387115 P12110-3

Frequencies

GnomAD3 genomes
AF:
0.179
AC:
27138
AN:
151980
Hom.:
2759
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.125
Gnomad AMI
AF:
0.146
Gnomad AMR
AF:
0.169
Gnomad ASJ
AF:
0.186
Gnomad EAS
AF:
0.307
Gnomad SAS
AF:
0.164
Gnomad FIN
AF:
0.0754
Gnomad MID
AF:
0.226
Gnomad NFE
AF:
0.219
Gnomad OTH
AF:
0.213
GnomAD3 exomes
AF:
0.179
AC:
20432
AN:
114234
Hom.:
2088
AF XY:
0.181
AC XY:
11094
AN XY:
61272
show subpopulations
Gnomad AFR exome
AF:
0.121
Gnomad AMR exome
AF:
0.155
Gnomad ASJ exome
AF:
0.178
Gnomad EAS exome
AF:
0.291
Gnomad SAS exome
AF:
0.149
Gnomad FIN exome
AF:
0.0747
Gnomad NFE exome
AF:
0.219
Gnomad OTH exome
AF:
0.190
GnomAD4 exome
AF:
0.217
AC:
295954
AN:
1360774
Hom.:
34441
Cov.:
32
AF XY:
0.216
AC XY:
144602
AN XY:
670540
show subpopulations
Gnomad4 AFR exome
AF:
0.115
Gnomad4 AMR exome
AF:
0.154
Gnomad4 ASJ exome
AF:
0.187
Gnomad4 EAS exome
AF:
0.385
Gnomad4 SAS exome
AF:
0.151
Gnomad4 FIN exome
AF:
0.0821
Gnomad4 NFE exome
AF:
0.228
Gnomad4 OTH exome
AF:
0.213
GnomAD4 genome
AF:
0.178
AC:
27144
AN:
152100
Hom.:
2760
Cov.:
34
AF XY:
0.173
AC XY:
12849
AN XY:
74364
show subpopulations
Gnomad4 AFR
AF:
0.125
Gnomad4 AMR
AF:
0.169
Gnomad4 ASJ
AF:
0.186
Gnomad4 EAS
AF:
0.307
Gnomad4 SAS
AF:
0.163
Gnomad4 FIN
AF:
0.0754
Gnomad4 NFE
AF:
0.220
Gnomad4 OTH
AF:
0.213
Alfa
AF:
0.189
Hom.:
952
Bravo
AF:
0.185
Asia WGS
AF:
0.220
AC:
767
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, criteria provided, single submitterclinical testingGeneDxJan 28, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesJan 07, 2016- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoAug 15, 2013- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jan 19, 2016- -
Myosclerosis Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Collagen 6-related myopathy Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Bethlem myopathy 1A Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
not provided Benign:1
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
3.4
DANN
Benign
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00018
dbscSNV1_RF
Benign
0.016
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs73159701; hg19: chr21-47540421; COSMIC: COSV56014168; COSMIC: COSV56014168; API